PharmaShots Weekly Snapshot (April 29-May 03, 2019)
1.AstraZenecas Qternmet XR (dapagliflozin, saxagliptin, metformin hydrochloride) Receives FDAs Approval for Type-2 Diabetes in the US
Published: May 03, 2019 | Tags: AstraZeneca, Qternmet XR, dapagliflozin, saxagliptin, metformin hydrochloride, Receives, FDA, Approval, Type-2 Diabetes, US
Published: May 02, 2019 | Tags: Celgene, Collaborates, Presage, Evaluate, Therapies, CIVO Technology, Multiple Cancers
3.Boehringer Ingelheim Signs a Clinical Research Agreement with Amal for the Evaluation of Combination Therapy to Treat Stage IV Colorectal Cancer
Published: May 02, 2019 | Tags: Boehringer Ingelheim, Signs, Clinical Research Agreement, Amal, Evaluation, Combination Therapy, Stage IV, Colorectal Cancer
4. GSK Reports Results of Trelegy Ellipta in P-III CAPTAIN Study for Asthma
Published: May 02, 2019 | Tags: GSK, Reports, Results, Trelegy Ellipta, P-III, CAPTAIN Study, Asthma
Published: May 03, 2019 | Tags: AstraZeneca, Signs, Exclusive, Research, License, Option Agreement, Transgene, Co-develop, Oncolytic Immunotherapies, Invir.IO Platform
6. Sanofis Dengvaxia Receives FDAs Approval to Prevent Dengue in Endemic Region in the US
Published: May 01, 2019 | Tags: Sanofi, Dengvaxia, Receives, FDA, Approval, Prevent, Dengue, Endemic Region, US
7.Tmunity Signs an Exclusive Research Agreement with the University of California to Advance TCR Therapies for Pediatric Cancers
Published: May 01, 2019 | Tags:Tmunity, Signs, Exclusive Research Agreement, University of California, Advance, TCR Therapies, Pediatric Cancers
8. Eisai Terminates its Worldwide Development & Commercialization Agreement with Purdue Pharma for Lemborexant
Published: April 30, 2019 | Tags: Eisai, Terminates, Worldwide, Development, Commercialization, Agreement, Purdue Pharma, Lemborexant
Published: April 30, 2019 | Tags: Medtronic, Attain Stability Quad MRI SureScan Left Heart Lead, Receives, FDA, Approval, Heart Failure
10.Exelixis Initiates P-III COSMIC-313 Study of Triple Combination Therapy for Advanced Renal Cell Carcinoma
Published: May 01, 2019 | Tags: Exelixis, Initiates, P-III, COSMIC-313, Study, Triple Combination Therapy, Advanced, Renal Cell Carcinoma
11. Medtronic Launches Solitaire X Revascularization Device for Acute Ischemic Stroke in the US
Published: April 30, 2019 | Tags: Medtronic, Launches, Solitaire X Revascularization Device, US, Acute Ischemic Stroke
Published: April 30, 2019 | Tags: AbbVie, Skyrizi, risankizumab, Receives, European Commission, Approval, Moderate, Severe, Plaque Psoriasis
13.Roche Spin-Off Nimble Therapeutics to Commercialize its Drug Development Technology
Published: April 30, 2019 | Tags: Roche, Spins-Off, Nimble Therapeutics, Commercialize, Drug Development Technology
Published: April 30, 2019 | Tags: AbbVie, Mavyret, glecaprevir, pibrentasvir, Receives, FDA, Approval, All Genotypes, Hepatitis C, Pediatric Patients
Published: April 30, 2019 | Tags: Vertex, Kalydeco, ivacaftor, Receives, FDA, Approval, Treat, Cystic Fibrosis, Infants
16.Abbott Reports Results of High Sensitive Troponin-I Blood Test for Risk Assessment of Heart Diseases
Published: April 30, 2019 | Tags: Abbott, Reports, Results, High Sensitive Troponin-I Blood Test, Risk Assessment, Heart Diseases
17.AstraZeneca Collaborates with BenevolentAI to Develop Therapies for Chronic Kidney Disease and Idiopathic Pulmonary Fibrosis
Published: April 30, 2019 | Tags: AstraZeneca, Collaborates, Benevolent AI, Develop, Therapies, Chronic Kidney Disease, Idiopathic Pulmonary Fibrosis
18.Janssen Collaborates with Iktos for its Artificial Intelligence (AI) Technology
Published: April 29, 2019 | Tags: Janssen, Collaborates, Iktos, Artificial Intelligence, Technology
Published: April 30, 2019 | Tags: ViiV Healthcare, Files, NDA, Application, FDA, HIV-1, Infection, Adults
Published: April 30, 2019 | Tags: Sandoz, Signs, Agreement, EirGenix, Commercialize, Proposed Trastuzumab Biosimilar, HER2+, Cancer Tumors
21.Novo Nordisks Esperoct (turoctocog alfa pegol, N8-GP) Receives CHMPs Positive Opinion to Treat Hemophilia A in Adolescents and Adults
Published: April 26, 2019 | Tags: Novo Nordisk, Esperoct, turoctocog alfa pegol, N8-GP, Receives, CHMP, Positive Opinion, Treat, Hemophilia A, Adolescents, Adults
22. Acutus Medicals AcQMap Contact Mapping Software Receives CE Mark Approval
Published: April 26, 2019 | Tags: Acutus Medical, AcQMap Contact Mapping Software, Receives, CE Mark Approval, EU
23. Sanofi and Lexicons Zynquista (sotagliflozin) Receive EUs MAA to Treat Type-1 Diabetes in Adults
Published: April 26, 2019 | Tags: Sanofi, Lexicon, Zynquista, sotagliflozin, Receive, EU, MAA, Treat, Type-1, Diabetes, Adults
24.AstraZeneca and Mercks Lynparza (olaparib) Receive CHMPs Positive Opinion for 1L Maintenance Treatment of BRCA-Mutated Advanced Ovarian Cancer
Published: April 29, 2019 | Tags: AstraZeneca, Merck, Lynparza, olaparib, Receive, CHMP, Positive Opinion, 1L, Treatment, BRCA-Mutated, Advanced, Ovarian Cancer